Integra LifeSciences IART Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
Based on trailing twelve months.
The official record: Integra LifeSciences’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's free cash flow yield?
- Integra LifeSciences (IART) reported free cash flow yield of 2.6% in Q2 2024.
- How has Integra LifeSciences's free cash flow yield changed year-over-year?
- Integra LifeSciences's free cash flow yield decreased by 45.1% year-over-year, from 4.7% to 2.6%.
- What is the long-term trend for Integra LifeSciences's free cash flow yield?
- Over 3 years (2020 to 2023), Integra LifeSciences's free cash flow yield has grown at a -10.6% compound annual growth rate (CAGR), from 3% to 2.1%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.